NEPHROCARE — Nephro Care India Income Statement
0.000.00%
- IN₹1.37bn
- IN₹1.20bn
- IN₹887.35m
Annual income statement for Nephro Care India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 34.2 | 171 | 272 | 460 | 887 |
| Cost of Revenue | |||||
| Gross Profit | 19.4 | 121 | 181 | 330 | 624 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 34.1 | 145 | 213 | 425 | 848 |
| Operating Profit | 0.142 | 26.4 | 59.5 | 34.9 | 39.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.002 | 25.8 | 62.2 | 48.3 | 46.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.098 | 23.7 | 45 | 36.4 | 33.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.098 | 23.7 | 45 | 36.4 | 33.7 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.098 | 23.7 | 44.1 | 36.4 | 33.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.006 | 1.44 | 2.68 | 2.38 | 2.04 |
| Dividends per Share |